Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway

被引:151
作者
Foltz, IN
Lee, JC
Young, PR
Schrader, JW
机构
[1] UNIV BRITISH COLUMBIA,BIOMED RES CTR,VANCOUVER,BC V6T 1Z3,CANADA
[2] SMITHKLINE BEECHAM PHARMACEUT,KING OF PRUSSIA,PA 19406
关键词
D O I
10.1074/jbc.272.6.3296
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian mitogen-activated protein (MAP) kinase homologue p38 has been shown to be activated by pro-inflammatory cytokines as well as physical and chemical stresses. We now show that a variety of hemopoietic growth factors, including Steel locus factor, colony stimulating factor-1, granulocyte/macrophage-colony stimulating factor, and interleukin-3, activate p38 MAP kinase and the downstream kinase MAPKAP kinase-2. Furthermore, although these growth factors activate both p38 MAP kinase and Erk MAP kinases, we demonstrate using a specific inhibitor of p38 MAP kinase, SE 203580, that p38 MAP kinase activity was required for MAP kinase-activated protein kinase-2 activation. Conversely p38 MAP kinase was shown not to be required for in vivo activation of p90(rsk), known to be downstream of the Erk MAP kinases. Interleukin-4 was unique among the hemopoietic growth factors we examined in failing to induce activation of either p38 MAP kinase or MAP kinase-activated protein kinase-2. These findings demonstrate that the activation of p38 MAP kinase is involved not only in responses to stresses but also in signaling by growth factors that regulate the normal development and function of cells of the immune system.
引用
收藏
页码:3296 / 3301
页数:6
相关论文
共 46 条
[1]  
AHLERS A, 1994, BLOOD, V83, P1791
[2]  
BAGRODIA S, 1995, J BIOL CHEM, V270, P27995
[3]   The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumour necrosis factor [J].
Beyaert, R ;
Cuenda, A ;
VandenBerghe, W ;
Plaisance, S ;
Lee, JC ;
Haegeman, G ;
Cohen, P ;
Fiers, W .
EMBO JOURNAL, 1996, 15 (08) :1914-1923
[4]   SIGNAL-TRANSDUCTION VIA THE MAP KINASES - PROCEED AT YOUR OWN RSK [J].
BLENIS, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :5889-5892
[5]   AU-RICH ELEMENTS - CHARACTERIZATION AND IMPORTANCE IN MESSENGER-RNA DEGRADATION [J].
CHEN, CYA ;
SHYU, AB .
TRENDS IN BIOCHEMICAL SCIENCES, 1995, 20 (11) :465-470
[6]   SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1 [J].
CUENDA, A ;
ROUSE, J ;
DOZA, YN ;
MEIER, R ;
COHEN, P ;
GALLAGHER, TF ;
YOUNG, PR ;
LEE, JC .
FEBS LETTERS, 1995, 364 (02) :229-233
[7]   INDEPENDENT HUMAN MAP KINASE SIGNAL-TRANSDUCTION PATHWAYS DEFINED BY MEK AND MKK ISOFORMS [J].
DERIJARD, B ;
RAINGEAUD, J ;
BARRETT, T ;
WU, IH ;
HAN, JH ;
ULEVITCH, RJ ;
DAVIS, RJ .
SCIENCE, 1995, 267 (5198) :682-685
[8]   ACTIVATION OF THE MAP KINASE HOMOLOG RK REQUIRES THE PHOSPHORYLATION OF THR-180 AND TYR-182 AND BOTH RESIDUES ARE PHOSPHORYLATED IN CHEMICALLY STRESSED KB CELLS [J].
DOZA, YN ;
CUENDA, A ;
THOMAS, GM ;
COHEN, P ;
NEBREDA, AR .
FEBS LETTERS, 1995, 364 (02) :223-228
[9]   P21RAS ACTIVATION VIA HEMOPOIETIN RECEPTORS AND C-KIT REQUIRES TYROSINE KINASE-ACTIVITY BUT NOT TYROSINE PHOSPHORYLATION OF P21RAS GTPASE-ACTIVATING PROTEIN [J].
DURONIO, V ;
WELHAM, MJ ;
ABRAHAM, S ;
DRYDEN, P ;
SCHRADER, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (05) :1587-1591
[10]   SIGNALING BY RECEPTOR TYROSINE KINASES [J].
FANTL, WJ ;
JOHNSON, DE ;
WILLIAMS, LT .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :453-481